Anticoagulation in syncardia total artificial heart recipients: anti-factor Xa or activated partial thromboplastin time?

Monteagudo-Vela, María; Bowles, Christopher; Raj, Binu; Robinson, Derek; Simon, Andre

Monteagudo-Vela, María; Bowles, Christopher; Raj, Binu; Robinson, Derek; Simon, Andre.

Afiliación

Monteagudo-Vela M; Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Harefield Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.
Bowles C; Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Harefield Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.
Raj B; Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Harefield Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.
Robinson D; Department of Mathematics, 3A20 Pevensey 2 Building, University of Sussex, Falmer Campus, Brighton, UK.
Simon A; Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Harefield Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.

Interact Cardiovasc Thorac Surg ; 34(2): 322-325, 2022 01 18.

Article en En | MEDLINE | ID: mdl-34849924

Asunto(s)

Corazón Artificial; Heparina; Anticoagulantes/efectos adversos; Monitoreo de Drogas/métodos; Inhibidores del Factor Xa/efectos adversos; Heparina/efectos adversos; Humanos; Tiempo de Tromboplastina Parcial; Estudios Retrospectivos

Palabras clave

Anti-FXa assay; Anticoagulation protocol; Total artificial heart; aPTT

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Heparina / Corazón Artificial Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Interact Cardiovasc Thorac Surg Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google